Search
IPO Approval for Fengbei Biotechnology on the Shanghai Stock Exchange Main Board
2025-08-07 /
Read about 0 minute
Author：小编
The Listing Review Committee of the Shanghai Stock Exchange has granted its approval for the initial public offering (IPO) of Suzhou Fengbei Biotechnology Co., Ltd., signifying a significant milestone in the company's journey towards listing on the prestigious Shanghai Stock Exchange Main Board.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
